SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ)

$22.8 0.09 (0.3963%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 72

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) News Sources

Syndax Announces Publication of SAVE Data on Revuforj® (revumenib) in Combination with Decitabine/Cedazuridine and Venetoclax in Relapsed/Refractory NPM1m, KMT2Ar, and NUP98r AML in the Journal of Clinical Oncology

11-06-2026

yahoo.com

Syndax Showcases Revuforj® (revumenib) Clinical Activity in Multiple Acute Leukemia Subtypes and Settings at EHA 2026

11-06-2026

yahoo.com

Syndax Pharmaceuticals (SNDX) Is Up 5.2% After Strong All-Oral Revuforj SAVE Trial Data - What's Changed

13-06-2026

yahoo.com

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

23-06-2026

247wallst.com

Is Syndax Pharmaceuticals, Inc. (SNDX) Stock Still a Biotech Opportunity After Revised AML Market Estimates?

30-06-2026

yahoo.com

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

01-07-2026

yahoo.com

Syndax to Highlight Late-Stage Programs and Unveil New Pipeline Assets at R&D Event

14-07-2026

yahoo.com

Wall Street Analysts Think Syndax (SNDX) Could Surge 70.38%: Read This Before Placing a Bet

14-07-2026

yahoo.com

Syndax Pharmaceuticals Maps Growth Beyond Revuforj With Lung Cancer, Myelofibrosis Push

14-07-2026

marketbeat.com

Syndax Pharmaceuticals (SNDX) Is Up 8.20% in One Week: What You Should Know

17-07-2026

yahoo.com

SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) Sentiment Trend

0 25 50 75 100 54 83 90 30 94 79 89 10 92 93 11-06-2026 13-06-2026 23-06-2026 30-06-2026 01-07-2026 14-07-2026 17-07-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) FAQs

toggle

What is the current price of SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ)?

The current price of SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) is $22.8.


toggle

SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) absolute price change since previous trading day?

The absolute price change of SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) since the previous trading day is $0.09.


toggle

SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) percentage price change since previous trading day?

The percentage price change of SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) since the previous trading day is 0.3963%.


toggle

What is the most recent average sentiment score for SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ)?

The most recent average sentiment score for SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) is 72 out of 100.


toggle

What is the most recent average sentiment for SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ)?

The most recent sentiment for SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ) is .


SEC-8K** Filing Available For SYNDAX PHARMACEUTICALS INC (SNDX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.